HCC risk prediction may be poorly reported and biased for individuals with nonviral chronic liver disease.

Amid skyrocketing audit and denial rates, slower reimbursements, and lower dollars paid per claim, continuous risk monitoring will be crucial to financial stability in 2025. WELLESLEY, MA / ACCESSWIRE ...

Musician Megan Thee Stallion visits WIRED to answer her most searched for questions on Google. Where did Megan Thee Stallion ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agree ...

Junaluska Sanitary District has been awarded $9.5 million from the N.C. Drinking Water State Revolving Fund to upgrade the ...

As students prepared to return to the classroom following the campus closure from Hurricane Helene’s impacts, they not only worked to help their own family and friends but also to help neighbors and ...

The agreement builds on a clinical collaboration between the companies pursuant to which amezalpat was combined with ...

Symptoms can include upper abdominal pain, yellow discolouration of the skin and general widespread weakness in the body.

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence ...

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include ...